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Abstract
With high-throughput technologies providing vast amounts of data, it has become more important to provide sys-
tematic, quality annotations.The Gene Ontology (GO) project is the largestresource for cataloguing gene function.
Nonetheless, its use is not yet ubiquitous and is still fraught with pitfalls. In this review, we provide a short primer
to the GO for bioinformaticians. We summarize important aspects of the structure of the ontology, describe
sources and types of functional annotations, survey measures of GO annotation similarity, review typical uses of
GO and discuss other important considerations pertaining to the use of GO in bioinformatics applications.
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INTRODUCTION
The first attempts at classifying gene functions made
use of natural language annotations in databases.
Early on it was found that natural language by
itself is too vague and unspecific to accurately capture
the function of genes [1], as it is difficult to perform
searches and establish relationships with natural lan-
guage annotations. The first efforts towards a struc-
tured and controlled annotation of genes were
schemes such as the enzyme classification (EC)
system representing the function of an enzyme
using a four digit sequence of numbers [2]. Such
classification schemes are still widely used but were
found to be insufficient to accurately describe gene
function. This motivated the introduction of the
Gene Ontology (GO) [3], which has grown to be
the largest resource of its kind.
The ‘GO Consortium’ consists of a number
of large databases working together to define stan-
dardized ontologies and provide annotations to the
GO. The three ontologies it encompasses are non-
redundant and share a common space of identifiers
and a well-specified syntax. Apart from providing a
standardized vocabulary for describing gene and gene
product functions, one key motivation behind the
GO was the observation that similar genes often
have conserved functions in different organisms.
The combination of information from all organisms
in one central repository makes it possible to inte-
grate knowledge from different databases and to
infer the functionality of newly discovered genes.
Originally, the GO was developed for a general
eukaryotic cell [3]. The initial GO vocabulary, as
well as the available GO term annotations present
in the first years of its existence reflects this fact
(Figure 1). However, the GO Consortium now
includes several annotation groups that focus on pro-
karyotes [5], further contributing to the expansion of
the vocabulary and annotations.
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the GO for bioinformaticians. After a brief introduc-
tion to the structure of the ontology, we discuss the
different types of annotations associated with the
GO. Not all annotations are assigned in the same
way and some are more trustworthy than others.
Computational inference methods are described
in more detail in this section, as they are used
to assign a large fraction of GO annotations. The
subsequent section discusses common measures of
similarity to compare the function of genes quantita-
tively. The last section reviews typical uses of the
GO and common pitfalls for the novice GO user.
WHAT IS THE GO?
The GO is a structured and controlled vocabulary
of terms. The terms are subdivided in three non-
overlapping ontologies, Molecular Function (MF),
Biological Process (BP) and Cellular Component
(CC) [6]. Each ontology describes a particular
aspect of a gene or gene product functionality, as
well as the relations between the terms. These rela-
tions are either ‘is_a’, ‘part_of’, ‘has_part’ or ‘regu-
lates’ relationships. There are two subclasses of the
‘regulates’ relationships: ‘positively regulates’ and
‘negatively regulates’. The ‘is_a’ relationship is not
used to imply that a term is an instance of another
term; instead, it connects a subtype to its more gen-
eral counterpart (Figure 2). The ‘part_of’ and
‘has_part’ relationships are logical complements of
each other [7]. The relationships form the edges of
a Directed Acyclic Graph (DAG), where the terms
are the nodes (Figure 2). This allows for more flex-
ibility than a hierarchy, since each term can have
multiple relationships to broader parent terms and
more specific child terms. Any path from a term
towards the root becomes more general as terms
are subsumed by parent terms.
Each gene is associated with the most specific set
of terms that describe its functionality. By definition,
if a gene is associated with a term, it is also associated
with all the parents of that term. The annotation
process is discussed in more detail in the next section.
The GO undergoes frequent revisions to add new
relationships and terms or remove obsolete ones. If a
term is deleted from the ontology, the identifier
for the term stays valid, but is labelled as obsolete
and all relationships to the term are removed [8].
Changes to the relationships do not affect annota-
tions, because annotations always refer to specific
terms, not their location within the GO.
Figure 1: Increase in the number of experimentally verified GO term assignments available for the respective
organism between September 2002 and September 2010.The GO consortium was initially focused on Eukaryotes,
a fact reflected in the distribution and increase of annotations available in the GO database.Contrast for instance
the steady growth of experimentally verified annotations for A. thaliana, S. cerevisiae or M. musculus with the sharp
increment in the number of experimentally verified annotations available for E. coli:f r o m3 3i n2 0 0 2t o1 8 5 2i n2 0 1 0 .
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ontologies exist. For example, an instance of a BP
is the execution of one or more MFs [9]. Similarly,
relationships exist between the MF and CC ontolo-
gies. Recently, these relationships have been
integrated into the GO by introducing some inter-
ontology links [7]. It should be noted that for the
moment there are two concurrent versions of the
GO, the filtered and the full GO. The main differ-
ence is that the filtered GO does not contain any
‘has_part’ or inter-ontology relationships. Many of
the analysis tools can only use the filtered GO.
Thus, the full expressivity of the GO structure is
not always available.
WHERE DOANNOTATIONS COME
FROM?
Annotations connect genes and gene products to GO
terms. Each annotation in the GO has a source and a
database entry attributed to it. The source can be a
literature reference, a database reference or compu-
tational evidence [4, 6]. In addition, there are three
qualifiers used to modify the interpretation of an
annotation, ‘contributes_to’, ‘colocalizes_with’ and
‘NOT’, making them an integral part of the annota-
tion [8].
Perhaps the most important attribute of an anno-
tation is the evidence code. The 18 evidence
codes available describe the basis for the annotation
(Figure 3). These evidence codes are divided into
four categories. General guidelines for deciding
which evidence code to use are given in Figure 4.
It should be kept in mind that one gene can be
annotated to the same term with more than one
evidence code and that multiple annotations to the
same term for the same gene could even share the
same reference. This makes it possible to see whether
an annotation is supported by more than one type of
evidence. However, if the gene is annotated with
more than one evidence code and one evidence
code is a superclass of another, the annotation with
the more general evidence code does not need to be
specified explicitly.
INFERRED FROM EXPERIMENT
The most reliable annotations are those inferred
directly from experimental evidence. Such annota-
tions are also important to seed the ontology so that
the gene function of related genes can be inferred by
computational methods [10]. At present, most
researchers do not directly add their findings to the
GO. The largest fraction of manual annotations are
Figure 2: The structure of the GO is illustrated on some of the paths of term GO:0060491to its root term.Note
that it is possible for a term to have multiple parents.
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ture [11]. In principle, researchers directly annotating
genes they themselves characterized would be more
efficient, but this practice has not yet caught on
because annotation is time consuming and anno-
tation guidelines are complicated [12]. There are
efforts underway to make it compulsory for authors
to submit GO term suggestions with article
manuscripts [13]. A short overview of how annota-
tions are made is given in [9].
INFERRED FROM
COMPUTATIONAL METHOD
There are seven evidence codes associated with com-
putational inference, out of which six imply manual
Figure 4: A decision tree for deciding which evidence code to use. Figure adapted from http://www.geneontology
.org/GO.evidence.tree.shtml.
Figure 3: GO evidence codes and their abbreviations. Evidence code NR (not recorded) is used for annotations
assigned prior to the use of evidence codes, and is not assigned to new annotations.
726 du Plessis et al.curation (ISS, ISO, ISA, ISM, IGC, RCA). The
evidence code IEA is used for all inferences made
without any human supervision, regardless of the
method used. The IEA evidence code is by far the
most abundantly used evidence code (Figure 5).
The Gene Ontology Annotation project (GOA,
[14]) is the largest contributor of IEA annotations,
most of which are derived from the protein domain
database InterPro [15]. The guiding idea behind
computational function annotation is the notion
that genes with similar sequences or structures are
likely to be evolutionarily related, and thus, assuming
they largely kept their ancestral function, they might
still have similar functional roles today. In this sec-
tion, we briefly review the main computational
methods used to infer function. For an in-depth
treatment of the topic, we refer the interested
reader to two recent reviews [16, 17]. Alongside
each method mentioned here, we indicate the evi-
dence code that would be used to support the
respective GO annotation.
The most straightforward approach of computa-
tional functional annotation is to infer the function
of a gene based on the functions of genes returned by
a database search for similar genes. Traditionally,
only sequence similarity is used [18], but some meth-
ods also use structural similarity. For instance,
Liu et al. [19] introduced a method that makes use
of the similarity of protein surface pockets to infer
GO terms related to the protein. The ISS evidence
code was originally used for all annotations derived
from sequence-based analyses and is appropriate
when multiple kinds of computational evidence are
used. Note that annotations marked with ISS evi-
dence code can also be partly derived from structural
similarity.
ISS is a superclass for the ISA, ISO and ISM evi-
dence codes. The three sub-categories of the ISS
should be used when only one method was used
to make the inference. For example, to improve
the accuracy of function propagation by sequence
similarity, many methods take into account the phy-
logenetic relations of genes. Most of these methods
rely on orthology (ISO evidence code), because the
function of orthologs is believed to be largely con-
served across species [20]. In a typical analysis, char-
acterized and uncharacterized genes are clustered
based on sequence similarity measures and phyloge-
netic relationships. The function of unknown genes
is then inferred from the function of characterized
genes within the same cluster (e.g. [20,21]).
Alternatively, methods based on protein profiles
account for the fact that sequence conservation
might be very uneven across the length of two func-
tionally related genes. This is because the function of
a protein is often dictated not by the shape and
structure of the whole protein, but rather by specific
regions and residues, such as catalytic sites, prosthetic
group attachment sites or other binding sites [22, 23].
Another approach to function prediction consists of
supervised machine learning based on features derived
from protein sequence [24–27] (ISM evidence code).
Figure 5: The distribution of evidence codes among annotations in the GO on1April 2010.
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nces to learn features that can be used to infer gene
functions. Although few explicit assumptions about
the complex relationship between protein sequence
and function are required, the results are dependent
on the accuracy and completeness of the training
data.
As Rentzsch and Orengo [16] argue, one of the
biggest challenges of automated function prediction
is choosing the right threshold beyond which func-
tion can be propagated. Using a predefined cut-off
level is not a good practice as the optimal threshold
will vary depending on which genes are evaluated.
Indeed, there are several instances of proteins with
high sequence similarity but different functions, and
conversely, of proteins with similar function but
highly divergent sequences [28, 29] and the user of
annotations derived by computational methods
should always have these intricacies in mind.
INFERRED FROM AUTHOR
STATEMENT
Annotations in this group fall into two categories.
Traceable Author Statements (TAS) refer to papers
where the result is cited, but not the original evi-
dence itself, such as review papers. On the other
hand a Non-traceable Author Statement refers to a
statement in a database entry or statements in papers
that cannot be traced to another paper.
CURATOR STATEMENTAND
OBSOLETE EVIDENCE CODES
Three evidence codes fall in this category: IC, ND
and NR. If an assignment of a GO term is made
using the curator’s expert knowledge, concluding
from the context of the available data, but without
any ‘direct’ evidence available, the IC evidence code
is used. The ND evidence code indicates that the
function is currently unknown (i.e. that no charac-
terization of the gene is currently available). Such an
annotation is made to the root of the respective
ontology to indicate which functional aspect is
unknown. Hence, the ND evidence code allows
for a subtle difference between unannotated genes
and uncharacterized genes. Note that the ND code
is also different from an annotation with the ‘NOT’
qualifier (which indicates the absence of a particular
function). The NR evidence code labels annotations
that were made before the introduction of evidence
codes and as such may not be used for new annota-
tions. It is obsolete and has been superceded by the
ND evidence code. Although a few legacy NR
annotations remain within the GO they will prob-
ably be removed in the nearby future.
IMPORTANCE OF EVIDENCE AND
QUALIFIERS
GO annotations should always be considered with
their qualifier and evidence code. A qualifier, such as
‘NOT’, changes the interpretation of an annotation.
Similarly, although the evidence code is not a direct
measure of the quality of the annotation, some evi-
dence codes are regarded as more trustworthy.
Terms annotated with ND are typically ignored as
no knowledge is available on the function of these
genes. NR annotations are obsolete and should be
ignored since the evidence type used for the annota-
tion is not known.
Most studies also disregard all terms annotated
without curation (IEA) [30–33], consequently leav-
ing out more than 98% of the annotations in the GO
(Figure 5). The mistrust many researchers have
towards IEA annotations is backed by studies sug-
gesting that annotations from the available databases
should be used with caution [34]. One of the leading
factors why IEA annotations are not used is because
this often leads to circular reasoning when used
in computational analyses. On the other hand,
IEA annotations are useful in providing a first appr-
oximation to experimental biologists. Ultimately, no
annotations should be regarded with complete con-
fidence, as some studies show that even the curated
annotations in GO are not free from annotation
errors [35].
To estimate the reliability of unsupervised com-
putational assignments, we compared the September
2008 and September 2010 versions of GO annota-
tion data for four representative Eukaryotes
(Arabidopsis thaliana, Caenorhabditis elegans, Drosophila
melanogaster and Saccharomyces cerevisiae). We consid-
ered all IEA annotations of the 2008 database that
either had an experimental evidence code or were
completely absent in the 2010 release. We used the
annotations confirmed experimentally as surrogate
for correct predictions and the annotations dropped
from the database as surrogates for wrong predic-
tions. In addition, to estimate the coverage of com-
putational predictions, we computed the fraction of
newly added experimental annotations that had been
728 du Plessis et al.previously computationally predicted. This yielded
Figure 6.
Most terms lie in the upper half of the graph,
which suggests that most computational predictions
are correct. As one would expect, more general
terms tend to be better predicted, and in many
cases are better covered as well. A notable exception
is the term GO:0005515 (protein binding) in the MF
ontology. The reason for its particularly low cover-
age is likely due to its usage guideline: ‘Annotation
to this term should use the IPI evidence code so that
the protein being bound can be specified in the
with modifier of the evidence code’ (http://gowiki
.tamu.edu/wiki/index.php/Category: GO:0005515\_!
\_protein\_binding#Notes).
Terms falling in the bottom right part of the chart
have high coverage at the expense of accuracy.
Consider for instance term GO:0016021 (integral
to membrane) from the CC ontology: its immediate
parent term GO:0031224 (intrinsic to membrane),
is positioned in the top right corner of the chart.
This suggests that in this case, the computational
Figure 6: EstimationofcorrectnessandcoverageofcomputationallyinferredGOterms(IEA)fromSeptember2008.
The estimationisbasedon data for four wellannotatedEukaryotes:A. thaliana,C. elegans,Drosophilamelanogaster and
Saccharomyces cerevisiae. Confirmed predictions are those 2008 IEA annotations that were ‘promoted’ to one of
experimental evidence codes (EXP,IMP,IGI,IPI,IDA,IEP) in the September 2010 annotation file.Rejectedpredictions
are IEA annotations in 2008 that were subsequently removed.The X-axis is a measure of completeness (‘recall’). It
represents the fraction of genes having experimentally validated annotations, added in the 2008^10 period, that
were correctly predicted in the 2008 IEA annotations file. TheY-axis is a measure of correctness (‘precision’). It
represents the fraction of genes having IEA annotations in 2008, later confirmed by experimentally validated
annotations (in the 2008^10 period).The size of each bubble reflects the frequency of the respective GO term in
annotations assigned using experimental evidence codes and is a surrogate for the generality of the term:
the larger the bubble, more abundantly is the term used in GO experimental annotations.To minimize estimation
errors, terms included in the figure have at least five confirmed 2008 IEA annotations and five rejected IEA annota-
tions, resulting in 72 BP terms, 85 MF terms and 37 CC terms. The files containing annotations were downloaded
from the GOA database [14].
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slightly less specific. Overall, these results corroborate
the idea that unsupervised computational assign-
ments can provide first approximations or working
hypotheses that can be refined or verified in subse-
quent steps [11, 36].
HOWARE GOANNOTATIONS
COMPARED QUANTITATIVELY?
One of the main purposes of GO annotations is a
quantitative comparison of gene function. Such
comparison is based on a measure of function simi-
larity between two genes, defined over the GO
terms associated with these genes. In this section,
we review the main similarity measures commonly
used, with an attempt at motivating intuitively their
mathematical formulas. For a more thorough survey
of similarity measures and their mathematical proper-
ties, we refer the reader to more specialized reviews
[28, 37].
SIMILARITYOF TWO GO TERMS
We start with the simplest similarity measure, the
function similarity between two GO terms. One
early idea was to define the similarity as a function
of the distance between the two terms in the ontol-
ogy graph [38] or the length of their common path
from the root, i.e. the number of common parents
[39]. However, pure graph-based similarities suffer
from the fact that the depth of a term within the
ontology is not necessarily indicative of its specificity
[40]. This motivated the formalization of the notion
of specificity with the definition of the information
content (IC) of a given term:
ICðcÞ :¼ logpðcÞ,
where p(c) is the probability of term c [40]. Hence,
the root term, which is implied by all terms and thus
has a probability of 1, has an IC of 0. By contrast,
rare terms have a high IC. The term probabilities are
commonly estimated from their frequencies in the
entire database, i.e. the number of genes associated
with c, divided by the total number of genes in the
ontology [37].
Resnik [40] combined the notion of IC with the
ontology structure to define the similarity of two
terms as the IC of the most informative common
parent. Formally,
SimResnikðc1,c2Þ :¼ maxc2Sðc1,c2ÞICðcÞ,
where Sðc1,c2Þ is the set of all terms that subsume
both c1 and c2. A slight variation consists in taking the
IC of the lowest common parent [41], which coin-
cides in most cases with the most informative
common parent, but is faster to compute.
An inconvenient aspect of this measure is that it is
not normalized. To remedy this, Lin normalized the
measure between 0 (no similarity) and 1 (identical)
[42]:
SimLinðc1,c2Þ :¼
2   SimResnikðc1,c2Þ
ICðc1ÞþICðc2Þ
:
But due to the normalization, Lin’s measure does not
convey the specificity of the terms compared. As a
result, genes that are annotated to general terms tend
to have higher similarities on average than genes
annotated to specific terms.
This phenomenon is referred to as the ‘shallow
annotation problem’ [43]. This motivated Schlicker
etal. [44] to refine the measure by weighting it by a
factor accounting for the specificity of the terms:
SimSchlickerðc1,c2Þ :¼ SimLinðc1,c2Þð1   pðcMICAÞÞ,
where pðcMICAÞ is the probability of the most infor-
mative common ancestor of c1 and c2.
Though IC-based measures are less influenced by
the idiosyncrasies of the ontology structure than their
graph-based counterparts, they are still biased,
because some terms are used more often and some
research areas receive more attention than others
[28]. Another caveat is that in principle, different
relationships within the ontology should not be trea-
ted equally.
In practice this is often not done and often all
relationships are treated equally to simplify the ana-
lysis [43]. Furthermore, it should be noted that not
all relationships are represented equally within the
ontology [45]. While ‘is_a’ relationships alone form
a complete tree that can be used for comparisons the
same is not true for other relationships.
GO SIMILARITYOF TWO GENES
In the previous section, we discussed similarity mea-
sures for pairs of GO terms. In most studies, how-
ever, the analysis is at the level of genes, each of
which can be associated with more than one term.
The simplest approach consists in considering all pos-
sible pairs of GO terms associated with both genes
730 du Plessis et al.and to use either the average or the maximum simi-
larity as measures for the two genes [43, 45]:
GeneSimavgðG1,G2Þ :¼ avgc12TðG1Þ,c22TðG2ÞSimðc1,c2Þ
or
GeneSimmaxðG1,G2Þ :¼ maxc12TðG1Þ,c22TðG2ÞSimðc1,c2Þ,
where T(G) is the set of GO terms associated with
gene G.
However, both variants have flaws. The main pro-
blem of the average is that considering all pairs of
GO terms penalizes multifunction proteins: in parti-
cular, the similarity between a multifunction gene
and itself can be quite low, because the average
tends to be dominated by pairs of different GO
terms (Consider a gene with n GO terms. Of all
the pairs, the number of pairs involving identical
GO terms scales linearly in n, but the number of
pairs involving different GO terms scales quadrati-
cally). The maximum suffers from the opposite pro-
blem, namely that genes that differ in all but one
functional aspect will still show a high similarity
under this measure. To balance between the two,
Azuaje et al. [46] suggested computing the average
over the reciprocal best matching pairs only.
Instead of reducing gene similarity to the similarity
of paired GO terms, other measures consider all
implied GO terms at once. One such measure is
the Term Overlap (TO), which considers the
number of common terms between genes [47].
Note that the set of terms associated with a gene
by definition includes the parents of all terms a
gene is annotated with. A normalized version of
this measure also exists, but was found to suffer
from the shallow annotation problem [48]. Yet
another measurement converts genes into binary
vectors of length equal to the number of terms in
the ontology by setting the ithcomponent to 1 if the
gene is annotated with the corresponding term and 0
otherwise. The distance between two genes can then
be computed using a metric on the vector space,
such as the cosine of the angle between them [49].
Lastly, set similarity measures, such as the Jaccard
index, can also be used to compare the sets of
terms with which two genes are annotated [50].
COMPARING SIMILARITY
MEASURES
Various measures reviewed above formalize the
notion of function similarity in slightly different
ways. Thus, choosing the best measure is a subjective
decision. Conceptual arguments can suffice to dis-
qualify a measure if it has an obvious flaw, e.g. a
low reported similarity for identical genes or a high
reported similarity for completely different ones.
Else, several studies have attempted to compare func-
tional similarity measures in terms of how well they
correlate with other measures that are assumed apriori
to be linearly linked with function, such as sequence
similarity (e.g. [45, 48]) or gene co-expression levels
(e.g. [43]). But the strong premises of such assess-
ments undermine their usefulness, because one of
the main goals of defining a measure of gene func-
tion similarity is precisely to investigate the rela-
tionship between function and other aspects of
genes such as sequence or expression. Ultimately,
we believe that the choice of similarity measure
should be acknowledged as inherently subjective.
Instead of trying to identify the best measure, studies
should demonstrate that their conclusions are not
sensitive to the choice of similarity measure (as
done e.g. in [51]).
WHY USE THE GO?
The GO can be used as a database to look up genes
with similar functionality or location within the cell
[29]. In this way a search for interacting genes in one
organism or similar genes in two organisms can be
narrowed down. If the terms associated with genes
are too specific, more general parent terms can be
used to give a snapshot of an organism’s gene func-
tions that can more easily be compared with other
organisms [5]. Another standard use of the GO
is to reason across the relations using an automatic
logical inference tool [5]. Inferences can be made
by following simple rules, for example, if A ‘is_a’ B
and B is ‘part_of’’ C then A is also ‘part_of’’ C.I n
this way relations that are not immediately obvious,
but captured in the GO, can be automatically
uncovered.
The GO is frequently used to analyse the results of
high-throughput experiments. One possibility is to
infer the location or function of genes that are over-
or under-expressed [8, 12]. In functional profiling the
GO is used to determine which processes are differ-
ent between sets of genes. This is done by using a
likelihood-ratio test to determine if GO terms are
represented differently between the two gene sets
[8]. Both hypothesis-generating and hypothesis-
driven queries can be addressed in this way.
In hypothesis-generating queries, the goal is to find
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sets, whereas in hypothesis-driven queries, it is to test
if some set of terms are different. In hypothesis-
generating queries a multiple-test correction needs
to be applied, but because of the amount of terms
in the GO, the power of the test is significantly
reduced. Hypothesis-driven queries do not require
any multiple-test corrections. To reduce the effect
of doing a multiple-test correction the number of
tests done in hypothesis-generating queries need to
be minimized. This is commonly done by running
the query on a GO slim. A GO slim ontology is a
reduced subset of general terms [8]. The annotations
for a set of genes can then be mapped onto the GO
slim. Because of the structure of the GO, an annota-
tion may be mapped to many terms in the GO slim.
Another standard use of GO slims is to give a high-
level categorization of genes based only on the terms
within the GO slim. It should be added that there are
two types of GO slims. The first type is a subset of
the GO used to facilitate the examination of a parti-
cular taxon subdivision. The second type is a set of
broad GO terms used to aggregate the GO into large
bins used for the representation of annotation data.
Additionally, the GO is used to infer the function
of unannotated genes. Genes that behave similarly to
an unannotated gene are identified from the experi-
ment and their function is evaluated to be transferred
to the unannotated gene. Many of these assigned
terms will be false positives, but the correct terms
should appear more often than is dictated by
chance or indirect effects [5].
The GO is also used to infer protein–protein
interactions (PPI) [33]. Shin et al. [32] used both
PPI and GO data to show that interacting proteins
are colocated within the cell. Another approach is to
test the validity of inferred PPI networks by looking
at the functional similarity of genes within the GO
[30]. In this case, it is important that annotations
inferred from previous PPI studies (IPI evidence
code) are left out from the analysis.
A wealth of tools has been developed for applying
the GO to various tasks. Links to most of the more
prominent tools can be found on the GO website
(http://geneontology.org). To give broader access to
the GO, the GO consortium developed the AmiGO
application (http://amigo.geneontology.org) [52].
AmiGO can be used online from the GO website or
downloaded and installed. The application contains
interfaces for searching, visualizing and downloading
data in the GO. AmiGO also features BLAST search,
Term Enrichment and GO Slimmer tools. The
Term Enrichment tool is used for functional profil-
ing and the GO Slimmer is used to map annotations
to the terms within a GO slim. Lastly, AmiGO also
makes it possible to directly query the GO database.
There are many other tools available for analysing
GO data. Because not all the tools use exactly the
same methods the results can be very different and it
is recommended that researchers try a few different
tools before making an interpretation [8].
While it can be a powerful inference tool,
researchers using the GO should familiarize them-
selves with the structure of the ontology and also
with the methods behind the tools they use to
ensure that their results are valid.
CONCLUSION
The number of associations in the GO has grown
exponentially since its inception. There were 30654
associations on 1 July 2000 and 7781954 associations
on 1 July 2003 [6]. This number had grown to more
than 16 million in 2007 [8] and more than 55 million
in 2010. Due to the inference methods used, most of
the growth has been from IEA associations. In con-
trast, the curated associations component has only
grown linearly. The ontology itself has also been
steadily growing, from less than 5000 terms in
2000 [6] to more than 30000 in 2010. The
Reference Genome Project has been initiated to
focus the annotation efforts of various groups on a
number of predetermined homologous genes [10].
This will not only help in seeding the ontology,
but through a concentrated effort on certain
branches the overall structure of the ontology will
also be improved.
One shortcoming of the GO is that annotations
only describe the normal, healthy functioning of
genes [12]. In addition, data on functional coordina-
tion between multi-function genes are not explicitly
stored [31]. Another shortcoming is that until
recently no relationships between the three ontolo-
gies were recorded [7, 12]. Although inter-ontology
relationships are now recorded they are only
recorded in the full GO, which is not used by all
analysis tools, making it necessary to maintain two
versions of the GO.
The structure of the GO is predominantly the
result of painstaking manual curation over the past
10 years. Through many additions and changes the
GO has grown to be quite large and in many cases
732 du Plessis et al.the structure is not optimal anymore. More specific
subsets are available, in the form of a prokaryote
subset and GO slims. Although there are quite a
large number of GO slims available on the GO web-
site, only seven of them are actively maintained
(Of the seven GO slims that are maintained by the
GO consortium two are for specific organisms
(Schizosaccharomyces pombe and Candida albicans), two
are for broader classes of organisms (Yeast and
Plant slims) and one is a generic GO slim. In addition
there is also the UniProtKB-GOA and whole pro-
teome analysis and the Protein Information
Resource slim. These GO slims are included as
part of the GO flat file, but can also be downloaded
individually from the website). The manual creation
of GO slims is a painstaking process as the informa-
tion loss from both the graph-structure and the
gene-product annotation needs to be minimized
[53]. A recent paper discusses the automatic creation
of GO slims based on an information theoretic
approach [53]. The analysis in the paper shows that
the terms chosen for inclusion in existing GO slims
are not always ideal and often subject to a bias.
Recently, researchers have also used techniques
from information theory to automatically organize
and optimize the structure of the GO [54]. It is
likely that in the future such approaches will be
used more frequently for the construction and cura-
tion of both the full GO and GO slims.
There are a number of other ontologies and
schemes for cataloguing genes available to research-
ers. In order to centralize the data, projects have been
initiated to clean up and integrate ontologies [4, 16].
The most important such example is the Open
Biomedical Ontologies (OBO) group which,
guided by a set of principles similar to the ones the
GO was built upon, seeks to standardize bio-ontol-
ogies [4]. As part of their efforts the OBO developed
the OBO biological ontology file format for specify-
ing ontologies. Their efforts also include the OBO
Foundry, a group that is devoted to the integration
of ontologies according to the OBO principles. In
addition, this group is also concerned with removing
redundant ontologies and aligning the development
of ontologies by separate communities. An important
tool in the standardization of ontologies is the OBO-
Edit ontology editor (www.obo-edit.org) which is
developed and maintained by the GO consortium.
Linking ontologies will increase their usefulness
and power, but will also provide many more pitfalls
for inexperienced users. Probably the most
challenging aspect will be the integration of associa-
tions made from different types of evidence and
blending the contents of the different ontologies to
give maximal information while still remaining clear
and concise. These steps will be necessary to ensure
that both inter- and intra-ontology comparisons
return meaningful results.
Key Points
  The GO is a structured andcontrolled vocabularyof terms and
relationships for cataloguing gene function.
  Annotations in the GO can be experimentally or computation-
ally derived, different classes of annotations have different levels
of confidence.
  The vast majority of annotations in the GO are automatically
inferredandnotcurated.
  Terms in the GO can be compared based on their information
content, which is inversely proportional to the probability of a
term.
  Genescanbe comparedbasedon the terms that theyare anno-
tatedwith in the GO.
  The GO is a powerful tool for data analysis, but its usage is
fraught with pitfalls for inexperienced users, which could lead
to false conclusionsbeingdrawn.
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